These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34205627)

  • 21. A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.
    Tsai HI; Lo CJ; Lee CW; Lin JR; Lee WC; Ho HY; Tsai CY; Cheng ML; Yu HP
    Am J Transl Res; 2021; 13(1):372-382. PubMed ID: 33527031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Rotational Thromboelastometry to Identify Early Allograft Dysfunction after Living Donor Liver Transplantation.
    Lee CF; Hung HC; Lee WC
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
    Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
    Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive utility of the C-reactive protein to albumin ratio in early allograft dysfunction in living donor liver transplantation: A retrospective observational cohort study.
    Park J; Lim SJ; Choi HJ; Hong SH; Park CS; Choi JH; Chae MS
    PLoS One; 2019; 14(12):e0226369. PubMed ID: 31821367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Xie H; Zhang L; Guo D; Yang Z; Zhu H; Zhou K; Feng X; Wei Q; Xu X; Song P; Wen X; Li J; Liu J; Zheng S
    Transplantation; 2020 Jan; 104(1):79-89. PubMed ID: 31283675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation.
    Tsai HI; Lo CJ; Zheng CW; Lee CW; Lee WC; Lin JR; Shiao MS; Cheng ML; Yu HP
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30597989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated uric acid increases the risk for acute kidney injury.
    Lapsia V; Johnson RJ; Dass B; Shimada M; Kambhampati G; Ejaz NI; Arif AA; Ejaz AA
    Am J Med; 2012 Mar; 125(3):302.e9-17. PubMed ID: 22340933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
    Lee DD; Singh A; Burns JM; Perry DK; Nguyen JH; Taner CB
    Liver Transpl; 2014 Dec; 20(12):1447-53. PubMed ID: 25179581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-circular RNA signature of donor circFOXN2 and circNECTIN3 predicts early allograft dysfunction after liver transplantation.
    Wang K; Wei X; Wei Q; Lu D; Li W; Pan B; Chen J; Xie H; Zheng S; Xu X
    Ann Transl Med; 2020 Feb; 8(4):94. PubMed ID: 32175387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Lactate-to-Platelet Ratio: A Novel Predictor for Short-Term Early Allograft Failure After Liver Transplantation.
    Takahashi K; Nagai S; Gosho M; Kitajima T; Kim J; Oda T; Abouljoud M
    Transplant Proc; 2021 Dec; 53(10):2993-2999. PubMed ID: 34756715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of early allograft dysfunction on outcomes following liver transplantation.
    Hudcova J; Scopa C; Rashid J; Waqas A; Ruthazer R; Schumann R
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28004856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
    Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Antiphospholipid Antibody Positivity and Association of Pretransplant Lupus Anticoagulant Positivity With Early Allograft Dysfunction in Liver Transplantation.
    Kwon HM; Jung KW; Moon YJ; Jung HW; Park YS; Jun IG; Song JG; Hwang GS
    Transplant Proc; 2018 May; 50(4):1136-1141. PubMed ID: 29731081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.